NCIC Clinical Trials Group - Canadian Collaborating Clinical Trials Network

Igor Jurisica

CRC Tier 1 - Tools and resources for systematically discovering clinically-relevant biomarkers of cancer

Pancreas Trachea, bronchus and lung Breast Ovary Nasopharynx Prostate Leukaemia Oesophagus

Ruth E Patterson

Energetics & Breast Cancer: Obesity, Inflammation, Insulin Resistance & Risk

Breast

Nikhil C Munshi

Role of Combination Therapy with Novel Targeted Agents

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Susan Halabi

Validation of Prognostic and Pathway Signatures in Lethal Prostate Cancer

Prostate

Pathology

Robert L Comis

ECOG-ACRIN Operations Center

Trachea, bronchus and lung Pancreas Breast Nasopharynx Prostate Leukaemia Colorectum Bladder Multiple myeloma and immunoproliferative diseases Non-Hodgkin lymphoma

Manuel Caruso

A gene therapy strategy for recessive distrophic epidermolysis bullosa

Leukaemia

Richard Lee

Exploring c-Met and HER3 crosstalk by nano-proximity imaging for understanding its clinical significance in lung adenocarcinoma.

Trachea, bronchus and lung

Pathology

Steven M Dubinett

The UCLA-Boston University Lung Cancer Biomarker Development Laboratory

Trachea, bronchus and lung

Pathology

Robert M Williams

Multiple Myeloma and Cancer Therapies via Largazole Analogs

Multiple myeloma and immunoproliferative diseases Leukaemia

Pathology Hematology and hematologic malignancies